Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

Furthermore, 13.4% of patients saw 90% or more scalp hair ... 2% of the population at some point during their lifetime, alopecia areata can affect people of any age, gender, race, or ethnicity.

Furthermore, 13.4% of patients saw 90% or more scalp hair ... 2% of the population at some point during their lifetime, alopecia areata can affect people of any age, gender, race, or ethnicity ...

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the completion of full enrollment in ...

According to health professionals, an extremely common habit millions of people in Britain follow could be linked to hair ...

Tilray Beverages, a division of Tilray Brands, Inc. , is pleased to announce that its U.S. Beverage division has achieved a significant milestone, ranking #4 on the Brewers Association 2024 annual ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

Thermo Fisher Scientific Inc. TMO is slated to release first-quarter 2025 results on April 23, before market open. Thermo ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

Elizabeth Sevigny reached rock bottom when her hair started to fall out, but everything changed when she had a baby and ...